Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

19 June 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Loracarbef Articles

King Pharmaceuticals 2nd-qtr earnings leap 77%

25 July 2001

Eli Lilly signs glucagon deal with E-Z-EM

24 August 1999

King acquires certain rights to Lilly's Lorabid

5 August 1999

US Quarterly Financial Results Round-Up

23 April 1998

Lilly Signs $100 Million Antibiotic Deal With Dura

2 September 1996

Mixed Earnings But Strong Sales For US Companies

12 February 1996

Eli Lilly Opens Manufacturing Plant

6 March 1995

RECALL HITS 1st-QTR NET PROFITS AT LILLY

25 April 1994

LILLY RECALLS ANTIBIOTICS

11 April 1994

RESTRUCTURING CHARGES DEPRESS LILLY AND E KODAK

14 February 1994

ELI LILLY'S GERMAN SALES DECLINE

15 November 1993

NEW CHEMICAL ENTITIES LAUNCHED IN 1992

1 February 1993

JOB CUTS AT BRISTOL-MYERS SQUIBB

9 November 1992

BIOCRAFT SETS SIGHTS ON GENERIC CECLOR

17 February 1992

NEW CHEMICAL ENTITIES UPDATE FOR 1991

10 February 1992

DECEMBER US APPROS REVIEWED

20 January 1992

KYOWA HAKKO TO EXPAND OVERSEAS

13 January 1992

US FDA BEATS 1990 DRUG APPROVALS IN 1991

13 January 1992

Showing 1-18 of 18 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
  • Negative US patent ruling for Novo Nordisk on Prandin
  • Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • Daiichi Sankyo files for Japanese approval of Prasugrel
  • FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
  • Negative US patent ruling for Novo Nordisk on Prandin
  • Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • Daiichi Sankyo files for Japanese approval of Prasugrel

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS